Microalbuminuria and endothelial dysfunction in essential hypertension

[1]  A. Folsom,et al.  Associations of Factor VIII and von Willebrand Factor with Age, Race, Sex, and Risk Factors for Atherosclerosis , 1993, Thrombosis and Haemostasis.

[2]  M. Barbagallo,et al.  Sex hormones and hemostatic risk factors for coronary heart disease in men with hypertension , 1993, Journal of hypertension.

[3]  A. Nitenberg,et al.  Acetylcholine-induced coronary vasoconstriction in young, heavy smokers with normal coronary arteriographic findings. , 1993, The American journal of medicine.

[4]  F. Mosca,et al.  Microalbuminuria is a marker of left ventricular hypertrophy but not hyperinsulinemia in nondiabetic atherosclerotic patients. , 1993, Arteriosclerosis and thrombosis : a journal of vascular biology.

[5]  A. Blann,et al.  von Willebrand factor and endothelial damage in essential hypertension. , 1993, Journal of human hypertension.

[6]  G. Mariani,et al.  Coagulation and fibrinolytic system impairment in insulin dependent diabetes mellitus. , 1992, Thrombosis research.

[7]  F. Salazar,et al.  Renal effects of prolonged synthesis inhibition of endothelium-derived nitric oxide. , 1992, Hypertension.

[8]  R. Bigazzi,et al.  Prevalence of microalbuminuria in a large population of patients with mild to moderate essential hypertension. , 1992, Nephron.

[9]  K. Pennert,et al.  Reversal of left ventricular hypertrophy in hypertensive patients. A metaanalysis of 109 treatment studies. , 1992, American journal of hypertension.

[10]  J. Jansson,et al.  von Willebrand factor in plasma: a novel risk factor for recurrent myocardial infarction and death. , 1991, British heart journal.

[11]  A. Blann.  Increased circulating levels of von Willebrand factor antigen in smokers may be due to lipid peroxides , 1991 .

[12]  A. Quyyumi,et al.  Abnormal endothelium-dependent vascular relaxation in patients with essential hypertension. , 1990, The New England journal of medicine.

[13]  J. Vane,et al.  Regulatory functions of the vascular endothelium. , 1990, The New England journal of medicine.

[14]  A. Scanu,et al.  Lipoprotein (a). Heterogeneity and biological relevance. , 1990, The Journal of clinical investigation.

[15]  R. Pedrinelli,et al.  Reactive hyperemia during short-term blood flow and pressure changes in the hypertensive forearm. , 1990, Journal of hypertension.

[16]  J. Parrillo,et al.  Promotion and subsequent inhibition of plasminogen activation after administration of intravenous endotoxin to normal subjects. , 1989, The New England journal of medicine.

[17]  J. Cruickshank,et al.  Factor VII coagulant activity is strongly associated with the plasma concentration of large lipoprotein particles in middle-aged men. , 1989, Atherosclerosis.

[18]  C. Jackson,et al.  MICROALBUMINURIA AS PREDICTOR OF VASCULAR DISEASE IN NON-DIABETIC SUBJECTS Islington Diabetes Survey , 1988, The Lancet.

[19]  V. Nguyen.  Fibrinogen and risk of cardiovascular disease: Kannel WB, Wolf PA, Castelli WP, et al JAMA 258: 1183–1186 Sep 1987 , 1988 .

[20]  R. D'Agostino,et al.  Fibrinogen and risk of cardiovascular disease. The Framingham Study. , 1987, JAMA.

[21]  R. Ross.  The pathogenesis of atherosclerosis--an update. , 1986, The New England journal of medicine.

[22]  N. Shock,et al.  Association between blood pressure and the rate of decline in renal function with age. , 1984, Kidney international.

[23]  K. Mettinger.  A study of hemostasis in ischemic cerebrovascular disease. I. Abnormalities in factor VIII and antithrombin. , 1982, Thrombosis research.

[24]  H. Parving,et al.  Transcapillary Escape Rate of Albumin and Plasma Volume in Essential Hypertension , 1973, Circulation research.